- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Franciose to lead Siemens nuclear group
Siemens Medical Systems has appointed Barbara Franciose as groupvice president of its nuclear medicine group in Hoffman Estates,IL. Franciose replaces Thomas Cafarella, who led the divisionfor two years (SCAN 7/14/93). Franciose is a Siemens veteran
Siemens Medical Systems has appointed Barbara Franciose as groupvice president of its nuclear medicine group in Hoffman Estates,IL. Franciose replaces Thomas Cafarella, who led the divisionfor two years (SCAN 7/14/93).
Franciose is a Siemens veteran who previously headed the vendor'sangiography division, which is also located at the nuclear group'sHoffman Estates facility. She has an engineering background, withdegrees from the University of Illinois and Marquette University.
Franciose's appointment comes amid other recent personnel changesat Siemens' nuclear medicine group, including the appointmentof Randy Weatherhead as vice president of sales and marketing(SCAN 9/27/95).
Siemens has been trying to rebuild its once-dominant positionin the nuclear medicine industry, but has found the going toughdue to the slumping gamma camera market and stiff competitionfrom other vendors.
In other Siemens personnel moves, Wolfgang Kroll has been namedexecutive vice president of business administration and financeat the vendor's Iselin, NJ, headquarters. Paul Mathews was namedgroup vice president of the firm's electromedical group.
New Study Examines Agreement Between Radiologists and Referring Clinicians on Follow-Up Imaging
November 18th 2024Agreement on follow-up imaging was 41 percent more likely with recommendations by thoracic radiologists and 36 percent less likely on recommendations for follow-up nuclear imaging, according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
